drug · unknown
patient view →lucinactant
Phase 2updated 2mo agoby Lee's Pharmaceutical Holdings Ltd🔗 ChEMBL
Phase 2community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for respiratory distress syndrome in premature infants and newborn respiratory distress syndrome and 4 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that